US/UK/Canada

Share

About Us

InnovationsKapital was founded in 1994 and is a leading early stage venture capital firm for innovative growth companies in the Nordic region. The business, carried out from offices in Gothenburg and Stockholm, is focused on Nordic investments within ICT and Healthcare & Life Sciences - dynamic sectors that are rapidly expanding and where Nordic research plays an important role.

Pick a time period -
Tags ( Active)

InnKap 4 Partners L.P. acquires stake in Paxport

Paxport is a passenger management solution supplier for the charter leisure travel industry. Paxport’s main focus is to create a better travel experience for holiday charter passengers when they use a charter airline or a tour operator. Through this empowerment, high yield ancillary revenue streams are generated which has become an important financial component for the leisure travel industry.Paxport enables the charter airline business to move as the banking industry has done, allowing the passenger to do more themselves while adding value to the booking process. This reduces cost and

InnKap 4 Partners L.P. acquires stake in Oxeon AB

Founded in 2003, Oxeon has quickly established itself as the market leader in Spread Tow reinforcements. Use of these Spread Tow carbon reinforcements increases the mechanical performance of composite material products and reduces the weight. Utilization of Oxeon’s TeXtreme® Spread Tow Fabrics and TeXero® Spread Tow Tapes by manufacturers of advanced aerospace, automotive, racing, industrial and sports products in applications that have critical material performance requirements has affirmed the significance of Oxeon’s ultra light materials.   InnovationsKapital invests in Nordic high-

InnKap 4 Partners LP invests SEK 29.5 million in Gammadata AB to acquire shares and establish a long-term relationship

Gammadata is a leader within applied physics and operates within three areas; high end surface analysis instruments and vacuum equipment (VG Scienta), nuclear physics instruments that detects nuclear explosions (SAUNA Systems) and agency sales in the Nordic region of instruments from well-known brands (Gammadata Instruments). The Gammadata group was founded in 1986 by a group of physicists and research scientists from Uppsala University. Gammadata Group is established as a leader in the three areas of operations and serve customers across the globe. “We are very pleased to have InnKap 4

Microdata raises 10 million SEK to fund international expansion

Microdata Telecom Innovation AB is raising 10 million SEK from venture capital firm InnovationsKapital and from existing shareholders through an equity issuance. Microdata Telecom is currently expanding internationally to address a rapidly growing global market for Microdata Advanced Site Solutions ( MASS™ ) in the mobile infrastructure market. Through this equity infusion, we are able to further expand our marketing and sales internationally with our portfolio of state of the art radio products within Advanced Site Solutions says Mats Gustavsson, CEO and co-founder of Microdata. We believe

Medius is raising external capital to fund international expansion

Medius raises 25 million SEK from venture capital firm InnovationsKapital through an equity issuance.Medius, which prior to the equity issuance had been owned by management and personnel, has grown organically and profitably every year since its founding in 2002. The last three years (2006-2008), the company’s revenue has increased by 430% and is on target to reach 90 million SEK (or about 9 million Euro) in 2009. A strategic plan for 2010-2012 includes offering part of the company’s products in non-domestic markets, and in 2012, 40% of revenue is planned to come from markets outside of the

Hope for sufferers of post-amputation pain

January 2009, OsloChronic residual limb pain following amputation is a major problem for many patients, yet no effective pharmaceutical treatment is currently available. However, as a result of the very encouraging results of a Phase IIa study in amputated limb stump pain with a novel topical medication from SantoSolve, the company has just initiated recruitment in a 3 month multinational, double-blind, placebo-controlled Phase III study in 150 patients suffering moderateto- severe residual limb pain following amputation.The Phase IIa trial with SantoSolve’s development compound, 2PX,

Ludesi’s 2D Gel Image Analysis Enabled Discovery of Potential Therapeutic Targets for Melanoma Tumors

Ludesi’s Image and Data Analysis Helped Raise Confidence in Experimental Data where Conventional 2D Gel Software Did Not Provide Sufficient ConfidenceBoston, MA – October 14, 2008 – Ludesi Corporation, developer of the award-winning Ludesi Image Analysis Service and the Ludesi REDFIN software for two-dimensional electrophoresis gels, today announced that researchers at the University of Pennsylvania in Philadelphia, National Eye Institute at National Institutes of Health in Bethesda Maryland, and the University of North Carolina at Chapel Hill have been able to discover potential

Xtract, Innovator in Social Advertising Intelligence Raises EUR 7.5 Million

London, UK and Helsinki, Finland – July 8, 2008: Xtract, the leader and innovator in social advertising intelligence today announced that it has closed its series B round of funding with EUR 7,5 Million ($11.74M) from leading early-stage technology investors Creandum, ETF III advised by Eqvitec Partners and InnovationsKapital.Xtract enables mobile and online companies to refine their customer data creating highly accurate 3 Dimensional profiles combining social interactions, behaviour and demographic information. It answers a crucial need in the advertising industry by making the

Isconova secures 30 million Swedish kronor growth financing

Leading vaccine adjuvant provider set to grow in animal vaccine market and to unlock the value of its technology for human vaccinesUppsala, 27 June 2008.Isconova AB, announced today that it has secured financing of 30 million Swedish kronor ( 3,3 m€ ) from InnovationsKapital, a leading Nordic venture capital firm, and a group of private investors. Isconova is a pioneer in vaccine adjuvant technology, with a proprietary, safe and effective ISCOM technology."We are extremely pleased to have attracted the support of InnovationsKapital, who have a successful record of backing innovative

Syntensia Secures Expansion Financing

Leading Network Security-on-Demand Company Charts Further Growth in Emerging MarketsNEW YORK, June 3, 2008 - Syntensia AB, a pioneer in subscription Network Security-On-Demand solutions, has secured financing of $3.5 million with an option for an additional $4 million through a share issue directed to InnovationsKapital, a leading Nordic venture capital firm, and a group of private investors in Sweden and abroad. Syntensia chairman is John Wattin.Syntensia, headquartered in Stockholm and with sales offices in twenty major Indian cities, Philippines and Cambodia was established in 2005 by

SANTOSOLVE REPORTS POSITIVE PHASE II RESULTS IN PATIENTS WITH OSTEOARTHRITIS

SantoSolve, a biopharmaceutical company focused on developing novel pain therapies today announced positive results from its Phase II study of 2PX, the company’s topical analgesic, in patients with osteoarthritis (OA). The study, a multi-center, double-blind, placebo-controlled Phase II trial met its pre-specified primary endpoint: reduction in pain from baseline to study week 4 (p=0.038). The study demonstrated a 35% reduction in pain from baseline after 4 weeks of twice-daily administration of 2PX, as compared to a 21% reduction in the control group.The study evaluated 84 patients

SantoSolve raises USD 7 Million to support transition of promising pain reliever 2PX into Phase III clinical trial

November 7, 2007, OsloSantoSolve AS has completed a new financing round raising USD 7 million. The investments have been made by the Norwegian investors DnBNor, Gezina and Glastad Invest, together with the existing investors – Teknoinvest and InnovationsKapital.The company recently completed a Phase II trial in osteoarthritis for its lead product 2PX. The double-blind, placebo-controlled trial was conducted at multiple medical centers in the UK, Sweden and Norway and recruited patients with osteoarthritis who were suffering moderate-to-severe chronic pain. The results indicate that 2PX

Apptus expands with help of InnovationsKapital

Apptus Technologies AB – a Swedish challenger in the global market for search technology in the e-directory and e-commerce sector – announced today that InnovationsKapital, the leading Nordic private equity/venture capital fund has become a new investor in the company.Since its founding in 2000, Apptus Technologies has positioned itself as the leader in the e-directory and e-commerce sector in the Nordic countries. As a result, Apptus’ technology platform is currently used by top tier customers such as, Eniro, Hitta and CDON.COM. In collaboration with InnovationsKapital, Apptus will

Hexaformer expands following investment from InnovationsKapital

Hexaformer, a Swedish challenger on the global market for distribution transformers, today announced that the leading Nordic private equity/venture capital investment firm, InnovationsKapital, invests 30MSEK in the company. The investment makes it possible to expand sales and production for Hexaformer’s patented distribution transformers.During several years, Hexaformer has worked intensively to develop a new generation transformer, one that is significantly better and cheaper to produce compared to a conventional transformer. Up until now, Hexaformer has primarily sold prototypes, and

Spotfire acquired for 195 MUSD – InnovationsKapital makes a return on investment of 9X in cash

The IT company Spotfire has been acquired by TIBCO, a US software company quoted on Nasdaq. As a result of the deal, InnovationsKapital’s first fund, InnKap 1, can now be closed. The performance of this fund has been outstanding with investors receiving a return in excess of 7x on their investment. As a result InnKap 1 has achieved a unique position amongst the very best early stage European venture capital funds of this vintage.Spotfire achieved a return, in cash, of 9X of the investment and for InnovationsKapital, Spotfire is another success story in a line of recent successful

InnovationsKapital secures SEK 1 billion for new investments

InnovationsKapital, a well established independent early stage venture capital firm, is pleased to announce the closing of the fourth InnKap fund – InnKap 4 Partners. InnovationsKapital’s aggregated capital under management now amounts to EUR 317 million.As with previous funds, InnKap 4 Partners will focus on investing in innovative start-up and early stage growth companies operating in the Nordic region and active in the ICT and Healthcare & Life Sciences market sectors. Since 1994, InnovationsKapital has completed 56 investments, earned an excellent reputation and is now a preferred

LUDESI ACCELERATES GROWTH THROUGH INNKAP INVESTMENT

September 20, 2006, Lund, Sweden. Ludesi AB, a global provider of bioinformatics solutions to the life science industry, today announced that the leading venture capital firm InnovationsKapital invests SEK 25 million in Ludesi. By this transaction InnovationsKapital will join Ludesi’s current investors FöretagsByggarna and the Sixth AP Fund.The funding will allow Ludesi to roll out sales of Ludesi’s innovative and successful offering for image analysis of 2D electrophoresis gels and to expand the company’s product portfolio into other expression proteomics technologies according to customer

Martin Falkevall joins InnovationsKapital as a new Investment Director in the Information and Communication Technology sector

Martin Falkevall has joined InnovationsKapital, one of the leading start-up and early stage venture capitalists in the Nordic region, as an Investment Director in the Information and Communication Technology team based in Stockholm. Martin, who is 36, has 9 years experience in the Nordic venture capital industry. He was previously with Capman Capital Management and with Swedestart Management. He joined Swedestart in 1997 as an Analyst, became a Partner in 2000 and remained with them until they were acquired by Capman in 2002, when he became a Partner at Capman. He has a Bachelor of Science

21 Grams raises SEK 20 million from InnovationsKapital

21 Grams, a provider of postal management services, today announced that it has raised a SEK 20 million round of financing from the leading venture capitalist InnovationsKapital. The funding will allow 21 Grams to aggressively grow the business on the Nordic market and to expand into other European markets. 21 Grams offers postal management services to corporate customers by leveraging its technology leadership in postage optimisation, in combination with its unique set of knowledge and experience of post, print and document management software. 21 Grams allows customers to outsource their

Carmen Systems to be acquired by Boeing - InnovationsKapital makes a return on investment of 9X in cash

InnovationsKapital and other major shareholders have entered into an agreement to sell all of its interests in Carmen Systems to The Boeing Company. As a result, the net proceeds to InnovationsKapital are at least SEK 190 million, equivalent to 9 times the invested capital.InnovationsKapital has in total invested SEK 21 million. Since InnovationsKapital’s investment, Carmen Systems has developed into a leading resource optimization solution provider in the railroad and airline industries. Long term involvement pays off “Carmen is a good example on how InnovationsKapital invests in early

Syntune names Kevin Green as Vice President Marketing and Sales

Syntune AB, a developer of innovative single-chip tunable lasers and transmitters today announced that Kevin Green has joined the company as Vice President of Marketing and Sales. Kevin Green has over 20 years of experience marketing telecommunications devices, most recently as VP of Sales for LuminentOIC, the recognized leader in FTTX optical devices. Previously Mr. Green was COO of ExceLight Communications Inc., a wholly owned subsidiary of Sumitomo Electric Industries. His experience further includes various sales and marketing positions at AT&T/Lucent Microelectronics. Mr. Green holds a

Industry Veteran John Pilitsis Joins Syntune’s Board of Directors

Syntune AB, a developer of innovative single-chip tunable lasers and tunable transmitters today announced the election of John Pilitsis to its Board of Directors. Pilitsis is an 18-year veteran of AT&T / Lucent Technologies. He served as the president of Lucent Optoelectronics from 1993 to 1998, and is widely credited with leading the turnaround of the Optoelectronics organization. Under his stewardship, sales rebounded from $172 million to over $450 million, and return on sales went from negative 50% to a positive 11%. Subsequent positions include CEO of Fitel Technologies Inc. Most

Ulf Tossman joins InnovationsKapital as a new Investment Director in the Healthcare & Life Sciences sector

Ulf Tossman has joined InnovationsKapital, one of the leading start-up and early stage venture capitalists in the Nordic region, as Investment Director in the Healthcare & Life Sciences team. Ulf Tossman is based at the Stockholm office. Ulf Tossman has joined InnovationsKapital from Carnegie Asset Management where he held the position of Senior Portfolio Manager, managing a global life science fund. Prior to this he was Executive Vice President, Global R&D at Fresenius Kabi. He also gained extensive experience in drug development and the commercialisation process as Medical Director of

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Media